Last week, detailed analysis from The Lancet revealed further benefits of longer breastfeeding
. Also, synthetic breast milk replication
, which is important for gut health and for the infant formula market, was developed by a research team in Boston; and research from Harvard showed that a higher fiber diet in adolescence
can decrease the risk of breast cancer. Survey results from charity Diabetes UK
showed that food manufacturers need to listen to Britons regarding adding fat, salt and sugar to their products. Healthy eating problems for children in care homes
were addressed in a joint collaboration. Health Canada approved Taiyo’s Sunfiber health claims
for decreasing IBS and childhood constipation.
Research on the creation of regulatory T-cells
for immune tolerance to food allergies was released; and farm milk
was also shown to have protective qualities for children with asthma. New research has shown that Tocotrienol
(vitamin E) has a beneficial effect in type II diabetes.
Advances in eye health also featured this week: Kemin Industries and DSM’s ZeaONE brand of zeaxanthin
, which provides important benefits for eye health, cognition and skin health can now be sold in Brazil after gaining ANVISA approval; and Algatechnologies obtained verification by the Non-GMO Project (NGP) for their AstaPure natural astaxanthin – this ensures that the AstaPure natural astaxanthin
products are produced in compliance with the Non-GMO Project Standard, including ongoing testing of high-risk ingredients.